
NMPA Draft Clinical Guideline on Cardiac RF Ablation Devices – Implications for Boston Scientific, J&J, and Abbott
The NMPA released the “Draft Guideline on Clinical Evaluation for Cardiac Radiofrequency Ablation Devices” on July 2, 2026 for feedback. Feedbacks need to be submitted









